Medicine & Health

The National Institute on Aging of the National Institutes of Health (NIH) has awarded researchers at Washington University School of Medicine a five-year $9.1 million grant to study resilience in older adults before and during the COVID-19 pandemic, as well as the pandemic’s cognitive and emotional effects on older adults.

Washington University School of Medicine in St. Louis has joined the NIH’s SenNet, a national research network focused on understanding senescent cells, an elusive but important cell type that plays key roles in the diseases of aging.

New research from Washington University School of Medicine suggests that in-home falls can be reduced by nearly 40% with a community-based program that helps older adults make modifications to their homes to prevent such mishaps.

Washington University’s Meredith Jackrel and Jai Rudra and are researching nanofiber materials that will eliminate the need for vaccine adjuvants.

In the first clinical trial of nicotinamide mononucleotide (NMN), School of Medicine researchers have found that the compound previously demonstrated to counteract aspects of aging and improve metabolic health in mice also has clinically relevant effects in people.

More than 20 years after the launch of a landmark clinical trial led by the School of Medicine’s Michael A. Kass, MD, follow-up exams and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.

Zachariah Reagh, assistant professor of psychological and brain sciences in Arts & Sciences, has been named a “Rising Star” by the Association for Psychological Sciences.

Researchers at the School of Medicine have received three grants totaling more than $10 million to study the factors that contribute to deterioration in driving skills in older adults and to determine ways to identify people whose driving skills have begun to decline or are on the verge of slipping.

Researchers at Washington University School of Medicine, working in mice, have found that a molecule previously linked to diabetes, cancer and muscle atrophy also seems to be involved in the development of osteoarthritis. It may offer a useful treatment target.

Jeffrey Zacks’s latest research turns on its head some popular beliefs about memory, showing that a failed prediction isn’t simply a failure, but also a cue which can help people update their understanding — as long as they realize their prediction was wrong.